Every month, we’ll be going inside the lab to chat with some of the amazing researchers and scientists working in cystic fibrosis (CF). Today, we're talking with Yasmine. Yasmine is an early phase coordinator at Royal Brompton Hospital, where she works on genetic therapy trials.
NICE are currently evaluating the cost-effectiveness of Kaftrio, Orkambi and Symkevi. Following the committee meeting on 14 December 2023, we discuss likely next steps.
In this blog, Alice talks about changing her attitude and approach to her CF treatment as she gets older, as well as her love of travelling – and how that’s inspired her new children’s book!
Trust-funded lab-based researchers are making good progress in finding new ways to treat CF that would work for people with all forms of CF, including people who are not able to benefit from CFTR modulator medicines like Kaftrio. Some of their results were recently published, and we spoke to Dr Livia Delpiano and Dr Mike Gray to find out more.
